Geographic Atrophy

Latest News

Person filling out scorecard on clipboard Image credit: AdobeStock/RonAlvey
New national scorecard exposes insurance coverage disparities for vision-threatening disease treatments

May 26th 2025

The LMDD Eye Health Scorecard specifically evaluated insurance coverage for treatments addressing GA, neovascular AMD, and thyroid eye disease.

iRORA conversion found using fundus autofluorescence - Image credit: ©K Davis/peopleimages.com—stock.adobe.com
iRORA phenotypes characterized using fundus autofluorescence

May 23rd 2025

Scientists sitting in lab examining results Image credit: AdobeStock/CoetzeeRising/peopleimages.com
LumiThera announces top-line results from LIGHTSITE IIIB extension trial assessing the Valeda Light Delivery System

May 13th 2025

Cognition Therapeutics publishes topline results of oral candidate zervimesine for the treatment of geographic atrophy - Image credit: ©Milan—stock.adobe.com
Oral zervimesine reduced GA lesion growth in phase 2 study from Cognition Therapeutics

May 8th 2025

Boehringer advances 2 geographic atrophy candidates to phase 2 clinical trials - Image credit: ©Dzmitry—stock.adobe.com
Boehringer Ingelheim kicks off dual phase 2 clinical studies for geographic atrophy candidates

May 8th 2025

Video Series
Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.